Provided by Tiger Fintech (Singapore) Pte. Ltd.

TG Therapeutics

39.19
+0.35000.90%
Volume:1.31M
Turnover:51.43M
Market Cap:6.22B
PE:164.57
High:39.73
Open:38.77
Low:38.50
Close:38.84
Loading ...

TG Therapeutics (NasdaqCM:TGTX) Surges 28% Following US$23 Million Net Income Turnaround

Simply Wall St.
·
10 Mar

S&P 500 Pair, Warren Buffet Pick Lead Five Stocks Near Buy Points Amid Market Shakeout

Blockhead
·
09 Mar

Investing Action Plan: Inflation Data, Retail Earnings And The Secret Path To Drill, Baby, Drill

Blockhead
·
08 Mar

Why TG Therapeutics Stock Was Soaring This Week

Motley Fool
·
08 Mar

Stock Track | TG Therapeutics Surges 5% as Positive BRIUMVI Data Set for Presentation at AAN 2025

Stock Track
·
08 Mar

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

GlobeNewswire
·
07 Mar

This Biotech Stock Hits Buy Point After Earnings Burst

Blockhead
·
07 Mar

Stock Track | TG Therapeutics Soars 5% as BRIUMVI Propels Strong 2024 Results, Promising Pipeline Updates

Stock Track
·
04 Mar

TG Therapeutics Price Target Maintained With a $55.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Mar

Exploring 3 High Growth Tech Stocks In The US Market

Simply Wall St.
·
04 Mar

Why TG Therapeutics, Inc. (TGTX) Surged On Monday?

Insider Monkey
·
04 Mar

TG Therapeutics Inc (TGTX) Q4 2024 Earnings Call Highlights: Strong U.S. ...

GuruFocus.com
·
04 Mar

Q4 2024 TG Therapeutics Inc Earnings Call

Thomson Reuters StreetEvents
·
04 Mar

TG Therapeutics Reports Strong 2024 Financial Results and Outlook

TIPRANKS
·
04 Mar

Meta, Netflix Test These Upper Limits As Tesla Exits The Scene While This Biotech Booms

Blockhead
·
04 Mar

Sector Update: Health Care Stocks Rise Monday Afternoon

MT Newswires Live
·
04 Mar

TG Therapeutics Soars Nearly 18% as Strong Q4 Results Fuel Growth Optimism

GuruFocus.com
·
04 Mar

TG Therapeutics (NasdaqCM:TGTX) Reports US$108M Revenue For Q4 2024 With Net Income Of US$23M

Simply Wall St.
·
04 Mar

TG Therapeutics' Shares Rise on 4Q Swing to Profit, Outlook Tops Estimates

Dow Jones
·
04 Mar

BUZZ-TG Therapeutics rises on quarterly net product revenue beat

Reuters
·
04 Mar